Real-time enrollment status for this age-related macular degeneration clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 7:34 AM UTC
| NCT Number | NCT06541704 |
| Recruiting Status | Recruiting |
| Condition | Age-related Macular Degeneration |
| Phase | PHASE3 |
| Target Enrollment | 975 participants |
| Active Locations | 158 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | October 13, 2026 (2 days ago) |
As of October 15, 2026: Clinical trial NCT06541704 is currently recruiting participants. This phase3 study for age-related macular degeneration is actively seeking new participants at 158 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06541704 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 158 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06541704 was last updated 2 days ago (October 13, 2026). HelloStudys verifies this status automatically.